LLY

800.77

-0.47%↓

UNH

537.55

-0.92%↓

JNJ

151.14

+0.33%↑

ABBV

175.17

+0.23%↑

NVO

83.98

-1.12%↓

LLY

800.77

-0.47%↓

UNH

537.55

-0.92%↓

JNJ

151.14

+0.33%↑

ABBV

175.17

+0.23%↑

NVO

83.98

-1.12%↓

LLY

800.77

-0.47%↓

UNH

537.55

-0.92%↓

JNJ

151.14

+0.33%↑

ABBV

175.17

+0.23%↑

NVO

83.98

-1.12%↓

LLY

800.77

-0.47%↓

UNH

537.55

-0.92%↓

JNJ

151.14

+0.33%↑

ABBV

175.17

+0.23%↑

NVO

83.98

-1.12%↓

LLY

800.77

-0.47%↓

UNH

537.55

-0.92%↓

JNJ

151.14

+0.33%↑

ABBV

175.17

+0.23%↑

NVO

83.98

-1.12%↓

Inicio・Lista de Acciones・Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc

Abierto

Sector Salud

8.14 -2.63

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

8.11

Máximo

8.31

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	+24.46 upside

Dividendos
By Dow Jones
Próximas Ganancias	13 feb 2025

Noticias sobre sentimiento de mercado

By Acuity

50%

170 / 393 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

8.01 / 8.26 Soporte y Resistencia

Aurinia Pharmaceuticals Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

28 ene 2025, 21:55 UTC

Ganancias

Stryker Sees Further Organic Sales Growth in 2025

28 ene 2025, 21:46 UTC

Adquisiciones, fusiones, absorciones

Stryker to Sell Spinal Implants Business to Viscogliosi Brothers

28 ene 2025, 21:29 UTC

Principales Movimientos del Mercado

NextEra Energy Shares Fall After XPLR Ceases Distributions

28 ene 2025, 23:54 UTC

Ganancias

Starbucks Earnings and Store Sales Fall, but CEO Upbeat on Turnaround -- 2nd Update

28 ene 2025, 23:49 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

28 ene 2025, 23:47 UTC

Charlas de Mercado

Nikkei May Rise After U.S. Tech Shares Rebound on Wall Street -- Market Talk

28 ene 2025, 23:17 UTC

Charlas de Mercado

Ganancias

Global Equities Roundup: Market Talk

28 ene 2025, 23:17 UTC

Charlas de Mercado

Ganancias

Boeing Sentiment Could Be Improving Despite Cut to Cash Outlook -- Market Talk

28 ene 2025, 22:50 UTC

Charlas de Mercado

DeepSeek Could Attract More Small Companies to AI, Mark Cuban Says -- Market Talk

28 ene 2025, 22:30 UTC

Principales Noticias

Pork Giant Smithfield Returns to U.S. Stock Market -- Update

28 ene 2025, 22:23 UTC

Principales Noticias

White House Spending Freeze Tries to Flip Script on Busted Budget Process -- 2nd Update

28 ene 2025, 22:05 UTC

Ganancias

Ashland 1Q Adj EPS 28c >ASH

28 ene 2025, 22:04 UTC

Ganancias

Ashland Backs FY25 Sales $1.9B-$2.05B >ASH

28 ene 2025, 22:04 UTC

Ganancias

Ashland 1Q Sales $405M >ASH

28 ene 2025, 22:04 UTC

Ganancias

Ashland 1Q Cont Ops Loss/Shr $3.51 >ASH

28 ene 2025, 22:03 UTC

Ganancias

Ashland 1Q Loss/Shr $3.50 >ASH

28 ene 2025, 21:57 UTC

Ganancias

Amazon Stock Sets a Record. Analysts Expect More Gains. -- Barrons.com

28 ene 2025, 21:56 UTC

Principales Noticias

White House Orders Pause of Federal Financial Assistance Programs -- 5th Update

28 ene 2025, 21:53 UTC

Principales Noticias

Ganancias

Starbucks Earnings and Store Sales Fall, but CEO Upbeat on Turnaround -- Update

28 ene 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

28 ene 2025, 21:41 UTC

Principales Noticias

Earnings Are Tech's Next Chance to Push Back on DeepSeek Worries -- Barrons.com

28 ene 2025, 21:36 UTC

Ganancias

Starbucks Earnings Beat Expectations. The Firm Is "Moving Quickly," Says CEO. -- Barrons.com

28 ene 2025, 21:25 UTC

Ganancias

Chubb Ltd 4Q Tangible Book Value Per Shr $100.38 >CB

28 ene 2025, 21:25 UTC

Ganancias

Chubb Ltd 4Q Book Value Per Shr $159.77

28 ene 2025, 21:22 UTC

Ganancias

Boeing Confirms Its Bad Earnings. Why the Stock Is Higher. -- Barrons.com

28 ene 2025, 21:18 UTC

Ganancias

GM Earnings Beat Expectations. Why the Stock Is Getting Crushed. -- Barrons.com

28 ene 2025, 21:18 UTC

Ganancias

Chubb Ltd 4Q P&C Combined Ratio 85.7%

28 ene 2025, 21:17 UTC

Ganancias

Chubb 4Q Consolidated Net Premiums Written $12.1 B

28 ene 2025, 21:16 UTC

Principales Noticias

Nasdaq Gains 2% After $1 Trillion DeepSeek Rout -- WSJ

28 ene 2025, 21:15 UTC

Ganancias

Chubb Ltd 4Q EPS $6.33 >CB

Comparación entre iguales

Cambio de precio

Aurinia Pharmaceuticals Inc Esperado

Precio Objetivo

By TipRanks

24.46% repunte

Estimación a 12 meses

Media 10.28 USD 24.46%

Máximo 11 USD

Mínimo 9 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Aurinia Pharmaceuticals Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

Comprar

Mantener

Vender

De acuerdo con 4 analistas que ofrecen calificaciones bursátiles a para Aurinia Pharmaceuticals Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

8.01 / 8.26Soporte y Resistencia

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

There is one bullish event.

Sentimiento

By Acuity

170 / 393 Clasificación en Salud

Finanzas

Otras acciones del sector

LLY

Eli Lilly and Co.

800.77

↓-0.47%

UNH

UnitedHealth Group Inc

537.55

↓-0.92%

JNJ

Johnson and Johnson

151.14

↑ +0.33%

ABBV

AbbVie Inc

175.17

↑ +0.23%

NVO

Novo Nordisk A-S

83.98

↓-1.12%

Aurinia Pharmaceuticals Inc

Resumen

Variación precio

Recomendaciones

Dividendos

Noticias sobre sentimiento de mercado

Puntuación técnica

Aurinia Pharmaceuticals Inc Gráfico

Noticias Relacionadas

Comparación entre iguales

Aurinia Pharmaceuticals Inc Esperado

Precio Objetivo

Consenso

Puntuación técnica

Sentimiento

Finanzas

Otras acciones del sector